Results 81 to 90 of about 57,561 (211)

Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta‐analyses revisited

Journal of Thrombosis and Haemostasis, 2018
C. Wiedermann
semanticscholar   +1 more source

Real-world outcomes of unfractionated heparin plus antithrombin concentrate versus bivalirudin in adult patients undergoing extracorporeal membrane oxygenation. [PDF]

J Extra Corpor Technol
Arenella A, Zhou J, Oh J, Calloway M, Howden R, Bader SO.   +5 more
europepmc   +1 more source

Antithrombin III for critically ill patients.

Cochrane Database of Systematic Reviews, 2016
Mikkel Allingstrup, J. Wetterslev, Frederikke Ravn, A. Møller, A. Afshari   +4 more
semanticscholar   +1 more source

Correlation Between Von Willebrand Factor, Thrombin-Antithrombin Complex, and Disease Severity in Sickle Cell Disease: Implications for Thrombosis. [PDF]

J Blood Med
Onorhide AK, Nkarense OA, Banturaki A, Godwin U.   +3 more
europepmc   +1 more source

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

Journal of Clinical Investigation, 1990
J. Weitz, M. Hudoba, D. Massel, J. Maraganore, J. Hirsh   +4 more
semanticscholar   +1 more source

Serum Urate and Renal Dysfunction: Bidirectional Genetic Associations, External Validation, and Exploratory Multi-Omics Characterization of Antithrombin (SERPINC1) in Hyperuricemic Nephropathy. [PDF]

Genes (Basel)
Jin L, Wang F.
europepmc   +1 more source

An Exploratory Pilot Study of Coagulation- and Fibrinolysis-Related Proteins in Unexplained Infertility. [PDF]

Int J Mol Sci
Nandakumar M, Moin ASM, Sathyapalan T, Butler AE, Atkin SL.   +4 more
europepmc   +1 more source

Antithrombin III at admission as a new predictive factors for mortality in ECMO for cardiogenic shock caused by acute myocardial infarction. [PDF]

Sci Rep
Huang JB, Wei Z, Huang Z, Tang XG, Zeng DF, Huang KQ, Li J.   +6 more
europepmc   +1 more source

Functional, biochemical, and clinical characterization of natural mutations affecting arginine residues in the heparin-binding site of antithrombin. [PDF]

Hemasphere
Cifuentes-Riquelme R, de la Morena-Barrio ME, Miñano A, Garrido-Rodríguez P, Velasco F, Rojo-Carrillo JJ, López-Correas P, Zaragoza-Huesca D, Padilla J, Lozano ML, Bravo-Pérez C, Corral J.   +11 more
europepmc   +1 more source

Houston, we have a problem: Coagulation concerns during long‐term spaceflight

Experimental Physiology, Volume 111, Issue 9, Page 3880-3883, 1 September 2026.
Lewis Fall, Damian M. Bailey
wiley   +1 more source